3rd Drug Discovery Re-Invented Conference

21-24 February 2017
Cancun, Mexico

Emerging Role of Biotechs, Academics and Non-Profits

The third DDRI series will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models. The conference will also provide examples of successful strategies for advancing new drug candidates in this era of distributed discovery.

See the full programme on the conference website.